Page last updated: 2024-10-24

peptidyl-cysteine S-trans-nitrosylation

Definition

Target type: biologicalprocess

Transfer of a nitric oxide (NO) group from one cysteine residue to another. [PMID:19854201, PMID:20972425, PMID:20972426]

Peptidyl-cysteine S-trans-nitrosylation is a post-translational modification where nitric oxide (NO) reacts with a cysteine residue in a protein, forming an S-nitrosothiol (SNO) group. This process is crucial for regulating various cellular functions, including signaling, gene expression, and redox homeostasis.

Here's a detailed breakdown of the process:

1. **NO Generation:** NO is produced by nitric oxide synthase (NOS) enzymes, which catalyze the oxidation of L-arginine to L-citrulline and NO.

2. **NO Diffusion:** NO is a highly diffusible molecule that can readily cross cell membranes. It can then interact with various targets, including cysteine residues in proteins.

3. **S-Nitrosylation Reaction:** The reaction of NO with a cysteine residue involves a two-step process. First, NO reacts with a reactive oxygen species (ROS) like superoxide (O2-) to form peroxynitrite (ONOO-). Peroxynitrite can then directly nitrosylate cysteine residues, forming an SNO group. Alternatively, NO can react with a thiolate anion (RS-) on a cysteine residue, forming an SNO group.

4. **SNO Formation:** The resulting SNO group is a covalent modification that can alter the protein's structure, function, and interactions.

5. **Regulation of Protein Function:** S-nitrosylation can modulate protein activity in various ways, including:
* **Altering protein conformation:** The bulky SNO group can induce conformational changes, affecting protein folding and stability.
* **Modifying enzymatic activity:** S-nitrosylation can either activate or inhibit enzyme activity by affecting substrate binding or catalytic site accessibility.
* **Changing protein-protein interactions:** SNO groups can alter the binding affinity of proteins to other molecules, influencing signaling pathways and cellular processes.

6. **De-nitrosylation:** The SNO group can be removed by denitrosylase enzymes, restoring the cysteine residue to its native state. De-nitrosylation is essential for regulating the duration and specificity of S-nitrosylation.

7. **Biological Significance:** Peptidyl-cysteine S-trans-nitrosylation plays a vital role in various biological processes, including:
* **Cardiovascular system:** NO regulates vascular tone and blood pressure by modulating smooth muscle relaxation.
* **Nervous system:** NO is involved in synaptic plasticity, neurotransmission, and memory formation.
* **Immune system:** NO participates in immune responses by regulating immune cell activation and cytokine production.
* **Cellular signaling:** S-nitrosylation is a crucial signaling mechanism that mediates diverse cellular responses to stimuli.

8. **Pathological Implications:** Dysregulation of S-nitrosylation has been implicated in various diseases, including:
* **Cardiovascular disease:** Imbalances in NO signaling contribute to atherosclerosis, hypertension, and heart failure.
* **Neurodegenerative diseases:** Altered S-nitrosylation patterns are associated with Alzheimer's disease and Parkinson's disease.
* **Cancer:** S-nitrosylation can regulate tumor growth, angiogenesis, and metastasis.

In summary, peptidyl-cysteine S-trans-nitrosylation is a crucial post-translational modification that plays a fundamental role in regulating cellular function and signaling. This process involves the reversible formation of SNO groups on cysteine residues, impacting protein conformation, activity, and interactions. Dysregulation of S-nitrosylation can contribute to various diseases, highlighting its importance in maintaining cellular homeostasis.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Glyceraldehyde-3-phosphate dehydrogenaseA glyceraldehyde-3-phosphate dehydrogenase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04406]Homo sapiens (human)

Compounds (18)

CompoundDefinitionClassesRoles
coumarin2H-chromen-2-one: coumarin derivativecoumarinsfluorescent dye;
human metabolite;
plant metabolite
oxidopamineoxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
benzenetriol;
catecholamine;
primary amino compound
drug metabolite;
human metabolite;
neurotoxin
pentamidinepentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
aromatic ether;
carboxamidine;
diether
anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
ostholosthol: from Cnidium monnieri and Angelica pubescens (both Apiaceae); structure given in first sourcebotanical anti-fungal agent;
coumarins
metabolite
nicotinamide mononucleotideNicotinamide Mononucleotide: 3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN.nicotinamide mononucleotideEscherichia coli metabolite;
mouse metabolite
2-methyladeninemethyladenine : Any member of the class of 6-aminopurines that is adenine bearing a single methyl substituent.
isopentenyladenosineIsopentenyladenosine: N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators.

N(6)-(Delta(2)-isopentenyl)adenosine : A nucleoside analogue in which adenosine has been modified by substitution at the 6-amino nitrogen by a Delta(2)-isopentenyl group.
N-ribosyl-N(6)-isopentenyladenine;
nucleoside analogue
antineoplastic agent;
plant growth regulator;
plant metabolite
benzonidazolebenznidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitroimidazol-1-yl)acetic acid with the aromatic amino group of benzylamine. Used for treatment of Chagas disease.

benzonidazole: used in treatment of Chagas' disease
C-nitro compound;
imidazoles;
monocarboxylic acid amide
antiprotozoal drug
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
xanthyletinexanthyletine: structurecoumarins
metrifudil
seselinseselin: structure in first sourcecoumarinsmetabolite
n(6)-benzyladenosineN(6)-benzyladenosine: RN given refers to parent cpd
2-methyladenosine2-methyladenosine : A methyladenosine in which the methyl group is located at position 2 on the adenine ring.methyladenosine
n(6)-cyclopentyladenosine
l 783281L 783281: structure in first source
scopoletinhydroxycoumarinplant growth regulator;
plant metabolite
7-hydroxycoumarin7-oxycoumarin: derivatives have anti-oxidant properties

umbelliferone : A hydroxycoumarin that is coumarin substituted by a hydroxy group ay position 7.
hydroxycoumarinfluorescent probe;
food component;
plant metabolite